R. Douglas Hurt

16.4k total citations · 3 hit papers
273 papers, 12.8k citations indexed

About

R. Douglas Hurt is a scholar working on Physiology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, R. Douglas Hurt has authored 273 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Physiology, 43 papers in Molecular Biology and 30 papers in Public Health, Environmental and Occupational Health. Recurrent topics in R. Douglas Hurt's work include Smoking Behavior and Cessation (150 papers), Nicotinic Acetylcholine Receptors Study (40 papers) and Behavioral Health and Interventions (23 papers). R. Douglas Hurt is often cited by papers focused on Smoking Behavior and Cessation (150 papers), Nicotinic Acetylcholine Receptors Study (40 papers) and Behavioral Health and Interventions (23 papers). R. Douglas Hurt collaborates with scholars based in United States, Vietnam and United Kingdom. R. Douglas Hurt's co-authors include Ivana T. Croghan, Kenneth P. Offord, Darrell R. Schroeder, Christi A. Patten, Jon O. Ebbert, Lowell C. Dale, J. Taylor Hays, Monique E Muggli, David P.L. Sachs and Troy D. Wolter and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

R. Douglas Hurt

256 papers receiving 12.0k citations

Hit Papers

Biochemical verification ... 1996 2026 2006 2016 2002 1997 1996 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Douglas Hurt United States 56 8.3k 2.6k 2.4k 2.2k 1.7k 273 12.8k
Gary A. Giovino United States 63 8.9k 1.1× 1.3k 0.5× 3.8k 1.6× 2.2k 1.0× 1.2k 0.7× 168 13.7k
Andrew Hyland United States 68 12.6k 1.5× 1.2k 0.5× 5.0k 2.1× 3.1k 1.4× 1.0k 0.6× 363 16.7k
Terry F. Pechacek United States 55 9.5k 1.1× 1.1k 0.4× 3.7k 1.6× 2.2k 1.0× 988 0.6× 160 14.2k
Ahmed Jamal United States 36 10.2k 1.2× 1.0k 0.4× 4.1k 1.7× 2.5k 1.1× 1.1k 0.6× 72 14.8k
Joseph R. DiFranza United States 48 5.9k 0.7× 1.4k 0.5× 2.3k 1.0× 1.5k 0.7× 832 0.5× 152 8.4k
Erkki Vartiainen Finland 69 3.6k 0.4× 1.7k 0.7× 4.3k 1.8× 463 0.2× 1.8k 1.0× 299 17.1k
David M. Homa United States 33 7.7k 0.9× 665 0.3× 2.6k 1.1× 1.3k 0.6× 1.0k 0.6× 54 12.6k
Ralph S. Caraballo United States 40 5.8k 0.7× 792 0.3× 2.3k 1.0× 1.1k 0.5× 664 0.4× 72 8.8k
Ann McNeill United Kingdom 70 14.5k 1.7× 1.3k 0.5× 5.8k 2.4× 4.2k 1.9× 1.3k 0.7× 466 19.1k
Stephen Babb United States 29 6.3k 0.8× 628 0.2× 2.2k 0.9× 1.4k 0.6× 780 0.4× 69 9.5k

Countries citing papers authored by R. Douglas Hurt

Since Specialization
Citations

This map shows the geographic impact of R. Douglas Hurt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Douglas Hurt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Douglas Hurt more than expected).

Fields of papers citing papers by R. Douglas Hurt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Douglas Hurt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Douglas Hurt. The network helps show where R. Douglas Hurt may publish in the future.

Co-authorship network of co-authors of R. Douglas Hurt

This figure shows the co-authorship network connecting the top 25 collaborators of R. Douglas Hurt. A scholar is included among the top collaborators of R. Douglas Hurt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Douglas Hurt. R. Douglas Hurt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hurt, R. Douglas, et al.. (2014). Pharmacologic interventions for tobacco dependence. 2 indexed citations
2.
Ebbert, Jon O., Ivana T. Croghan, Darrell R. Schroeder, & R. Douglas Hurt. (2013). A Randomized Phase II Clinical Trial of High-Dose Nicotine Patch Therapy for Smokeless Tobacco Users. Nicotine & Tobacco Research. 15(12). 2037–2044. 6 indexed citations
3.
Hurt, R. Douglas. (2011). The Church & the Land: The National Catholic Rural Life Conference and American Society, 1923–2007 (review). ˜The œCatholic historical review. 97(1). 185–186. 1 indexed citations
4.
Hurt, R. Douglas, et al.. (2011). Preventing Lung Cancer by Treating Tobacco Dependence. Clinics in Chest Medicine. 32(4). 645–657. 10 indexed citations
5.
Croghan, Ivana T., et al.. (2011). Lessons learned on the road to a smoke-free Italy.. PubMed. 23(2). 125–36. 2 indexed citations
6.
Dale, Lowell C., Jon O. Ebbert, Elbert D. Glover, et al.. (2007). Bupropion SR for the treatment of smokeless tobacco use. Drug and Alcohol Dependence. 90(1). 56–63. 27 indexed citations
7.
Ebbert, Jon O., Amit Sood, J. Taylor Hays, Lowell C. Dale, & R. Douglas Hurt. (2007). Treating Tobacco Dependence: Review of the Best and Latest Treatment Options. Journal of Thoracic Oncology. 2(3). 249–256. 21 indexed citations
8.
Hurt, R. Douglas, Christi A. Patten, Kenneth P. Offord, et al.. (2005). Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinine.. Journal of Studies on Alcohol. 66(4). 506–516. 11 indexed citations
9.
Hurt, R. Douglas. (2004). Reflections on American agricultural history. 52(1). 1–19. 2 indexed citations
10.
Muggli, Monique E & R. Douglas Hurt. (2003). Tobacco industry strategies to undermine the 8th World Conference on Tobacco or Health. Tobacco Control. 12(2). 195–202. 17 indexed citations
11.
Hurt, R. Douglas. (2003). Norman Borlaug: Geneticist of the Green Revolution. 84(2).
12.
Cox, Lisa Sanderson, Christi A. Patten, Lois E. Krahn, et al.. (2003). The Effect of Nicotine Patch Therapy on Depression in Nonsmokers. Journal of Addictive Diseases. 22(4). 75–85. 6 indexed citations
13.
Patten, Christi A., R. Douglas Hurt, Kenneth P. Offord, et al.. (2003). Relationship of Tobacco Use to Depressive Disorders and Suicidality Among Patients Treated for Alcohol Dependence. American Journal on Addictions. 12(1). 71–83. 12 indexed citations
14.
Hays, J. Taylor, R. Douglas Hurt, Nancy A. Rigotti, et al.. (2001). Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation. Annals of Internal Medicine. 70 indexed citations
15.
Hurt, R. Douglas. (1999). The Influence of the Minnesota Tobacco Trial on the Healthcare Community and Tobacco Regulation. William Mitchell law review. 25(2). 9. 1 indexed citations
16.
Lawson, George M., R. Douglas Hurt, Lowell C. Dale, et al.. (1998). Application of Urine Nicotine and Cotinine Excretion Rates to Assessment of Nicotine Replacement in Light, Moderate, and Heavy Smokers Undergoing Transdermal Therapy. The Journal of Clinical Pharmacology. 38(6). 510–516. 33 indexed citations
17.
Sandborn, William J., William J. Tremaine, Kenneth P. Offord, et al.. (1997). Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis. Annals of Internal Medicine. 51 indexed citations
18.
Hurt, R. Douglas, et al.. (1994). Acute Effects of Transdermal Nicotine on Sleep Architecture, Snoring, and Sleep-Disordered Breathing in Nonsmokers. American Journal of Respiratory and Critical Care Medicine. 150(2). 469–474. 112 indexed citations
19.
Hurt, R. Douglas, et al.. (1988). Long-Term Follow-Up of Persons Attending a Community-Based Smoking-Cessation Program. Mayo Clinic Proceedings. 63(7). 681–690. 14 indexed citations
20.
Jaeger, Thomas M., et al.. (1988). Legionella bozemanii Pneumonia in an Immunocompromised Patient. Mayo Clinic Proceedings. 63(1). 72–76. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026